Mersana Therapeutics Inc (NASDAQ:MRSN) price on Thursday, March 20, fall -3.70% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.44.
A look at the stock’s price movement, the close in the last trading session was $0.46, moving within a range at $0.43 and $0.4467. The beta value (5-Year monthly) was 1.65. Turning to its 52-week performance, $5.11 and $0.43 were the 52-week high and 52-week low respectively. Overall, MRSN moved -20.65% over the past month.
Mersana Therapeutics Inc’s market cap currently stands at around $55.09 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-02.
The average forecast suggests down to a -34.63% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 27.11M, representing a -33.05% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that MRSN is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend MRSN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
MRSN’s current price about -11.78% and -26.47% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.55, while 7-day volatility ratio is 7.20% and 10.03% in the 30-day chart. Further, Mersana Therapeutics Inc (MRSN) has a beta value of 1.56, and an average true range (ATR) of 0.06. Analysts have given the company’s stock an average 52-week price target of $3, forecast between a low of $3 and high of $3. Looking at the price targets, the low is -581.82% off current price level while to achieve the yearly target high, price needs to move -581.82%. Nonetheless, investors will most likely welcome a -581.82% jump to $3 which is the analysts’ median price.
If we refocus on Mersana Therapeutics Inc (NASDAQ:MRSN), historical trading data shows that trading volumes averaged 2.59 over the past 10 days and 5.69 million over the past 3 months. The company’s latest data on shares outstanding shows there are 115.65 million shares.
The 31.15% of Mersana Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 54.62% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 10.32 million on 2025-02-28, giving us a short ratio of 2.26. The data shows that as of 2025-02-28 short interest in Mersana Therapeutics Inc (MRSN) stood at 1083.0 of shares outstanding, with shares short rising to 9.47 million registered in 2025-01-31. Current price change has pushed the stock -69.09% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the MRSN stock continues to rise going into the next quarter.
